查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813950

正压呼吸器市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2033 年

Positive Airway Pressure Devices Market Size, Share & Trends Analysis Report By Product (CPAP, APAP, BiPAP), By Application (OSA, COPD), By End Use (Home Care Settings, Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

正压呼吸器市场摘要

预计 2024 年全球正压呼吸器市场价值将达到 24.8 亿美元，到 2033 年将达到 40.4 亿美元，2025 年至 2033 年的复合年增长率为 5.60%。

这种增长是由睡眠呼吸中止症盛行率的增加、技术的进步、对睡眠障碍的认识和诊断的提高以及医疗保健基础设施的改善所推动的。

这些因素推动了全球对 PAP 机器的需求。不断增强的健康意识、更好的诊断方法和技术创新正在塑造市场未来的成长前景。阻塞型睡眠呼吸中止症是一种呼吸系统疾病，患者的呼吸模式不规律，导致脑部供氧减少。根据《沙乌地阿拉伯耳鼻喉头颈外科杂誌》于 2023 年发表的全球阻塞型睡眠呼吸中止症症的估计，约有 9.36 亿人患有轻度至重度睡眠呼吸中止症，其中 4.25 亿 30 至 69 岁的人患有中度至重度睡眠呼吸中止症。快速的全球化、不断变化的生活方式和不健康的饮食习惯是导致睡眠呼吸中止症流行的一些因素。此外，肥胖程度的增加和缺乏运动也推高了阻塞型睡眠呼吸中止症的盛行率。

睡眠障碍意识的提升和诊断水准的提高是推动市场成长的关键因素。随着人们对睡眠呼吸中止症及其潜在风险的了解不断加深，他们寻求诊断和治疗的可能性也随之增加。美国睡眠呼吸中止症协会等组织所进行的公共卫生宣传活动有助于提高人们的意识。此外，睡眠多项生理检查和居家睡眠测试等诊断方法的改进也使得及早发现睡眠呼吸中止症变得更加容易。随着睡眠呼吸中止症日益被视为一项严重的健康问题，越来越多的人正在接受PAP治疗，这进一步刺激了市场需求。

新冠疫情对呼吸器（PAP）市场产生了正面影响。美国国家生物技术资讯中心（National Center for Biotechnology Information）于2022年发表的一项研究发现，使用家用持续性正压呼吸器（CPAP）治疗阻塞型睡眠呼吸中止症中止症与住院新冠患者的预后不良无关，这表明​​在疫情期间可以安全地继续使用CPAP。据报道，远端医疗服务提高了CPAP的依从性，并在封锁期间增加了使用率，因为患者能够获得更好的远端支援。疫情凸显了PAP设备在管理睡眠障碍和维持重症患者呼吸健康的重要性。

此外，根据瑞思迈截至2024年6月30日财年的年度报告，新冠疫情影响了公司的销售，尤其是在睡眠和呼吸照护部门。报告指出，疫情期间人们对呼吸健康意识的增强，带动了瑞思迈气道正压通气（PAP）设备的需求增加。需求激增的原因是，新冠疫情相关呼吸系统疾病患者需要实用的非侵入性通气方案。瑞思迈等市场参与者的气道正压通气（PAP）设备销售额显着增长，这反映了其在管理睡眠併发症发挥的重要作用。

目录

第一章调查方法与范围

第二章执行摘要

第三章正压呼吸器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 正压呼吸装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
  • 法规概述
  • 技术概述（当前产品和下一代功能）
  • 正压呼吸器关键交易及策略伙伴关係分析
  • COVID-19的影响

第四章正压呼吸器市场：产品评估与趋势分析

  • 定义和范围
  • 2024年及2033年产品市占率分析
  • 细分仪表板
  • 2021-2033年正压呼吸器市场（依产品划分）
    • CPAP
    • APAP
    • BiPAP

第五章正压呼吸器市场：应用评估与趋势分析

  • 定义和范围
  • 2024 年和 2033 年应用市占率分析
  • 细分仪表板
  • 2021-2033年正压呼吸器市场（依应用）
    • 阻塞型睡眠呼吸中止症
    • 呼吸衰竭
    • COPD

第六章正压呼吸器市场：最终用途估计与趋势分析

  • 定义和范围
  • 2024年及2033年最终用途市占率分析
  • 细分仪表板
  • 2021-2033年正压正压呼吸器市场（依最终用途划分）
    • 医院和诊所
    • 居家照护环境
    • 其他（护理设施等）

第七章正压呼吸器市场：按地区、产品、应用和最终用途分類的区域估计和趋势分析

  • 区域仪表板
  • 2021-2033 年市场规模与预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 参与者概览
  • 2024年企业市场分析
  • CPAP设备市占率分析（2024年）
  • 2024 年 APAP 设备公司市占率分析
  • 2024年Bi-PAP呼吸器公司市占率分析
  • 公司分类
  • 公司简介/上市公司
    • Koninklijke Philips NV
    • Fisher &Paykel Healthcare Limited
    • ResMed
    • Drive DeVilbiss Healthcare
    • React Health（3B Medical）
    • BMC Medical
    • Armstrong Medical Inc.
    • Wellell（Apex Medical）
    • Breas Medical
    • SEFAM
    • Trudell Medical（Vyaire）
    • Lowenstein Medical UK Ltd
    • Transcend Inc.（Somnetics International, Inc.）
Product Code: GVR-3-68038-910-4

Positive Airway Pressure Devices Market Summary

The global positive airway pressure devices market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 4.04 billion by 2033, growing at a CAGR of 5.60% from 2025 to 2033. This growth is attributed to the increasing prevalence of sleep apnea, advancements in technology, rising awareness and diagnosis of sleep disorders, and improving healthcare infrastructure.

These factors are fueling the demand for PAP devices globally. Growing health concerns, better diagnostic methods, and technological innovations are shaping the market's future growth prospects. Obstructive sleep apnea is a respiratory disorder wherein the patient faces irregular breathing patterns with reduced oxygen supply to the brain. According to the Saudi Journal of Otorhinolaryngology-Head and Neck Surgery estimates on the global prevalence of obstructive sleep apnea published in 2023, approximately 936 million people are suffering from mild to severe sleep apnea, and among these, 425 million individuals in the age group of 30 to 69 years are suffering from moderate-to-severe sleep apnea. Rapid globalization, changing lifestyles, and unhealthy dietary habits are a few factors contributing to the prevalence of sleep apnea. In addition, growing obesity levels and a lack of physical activity are driving the incidence rate of obstructive sleep apnea.

Rising awareness and diagnosis of sleep disorders are crucial factors propelling market growth. As people become more educated about sleep apnea and its potential risks, they are more likely to seek diagnosis and treatment. Public health campaigns run by organizations such as the American Sleep Apnea Association have helped improve awareness. In addition, improved diagnostic methods such as polysomnography and home sleep tests have made identifying sleep apnea in its early stages easier. The increasing recognition of sleep apnea as a significant health concern drives more individuals to pursue PAP therapy, thus fueling market demand.

The COVID-19 pandemic had a positive impact on the PAP devices market. According to a study published by the National Centre for Biotechnology Information in 2022, obstructive sleep apnea treated with home CPAP was not associated with worse outcomes in hospitalized COVID-19 patients, suggesting that CPAP can be safely continued during the pandemic. Telehealth services improved CPAP adherence, with some reports showing increased usage during lockdowns as patients received better remote support. The pandemic has highlighted the importance of PAP devices in managing sleep disorders and supporting respiratory health in critically ill patients.

Furthermore, according to ResMed's annual report for the fiscal year ending June 30, 2024, the COVID-19 pandemic impacted the company's sales, particularly in its sleep and respiratory care segment. The report indicates an increased demand for ResMed's PAP devices due to the heightened awareness of respiratory health during the pandemic. This surge in demand was driven by the need for practical, non-invasive ventilation options for patients with respiratory issues related to COVID-19. Market players such as ResMed experienced strong revenue growth in its PAP device sales, reflecting its critical role in managing sleep apnea and respiratory complications associated with COVID-19.

Global Positive Airway Pressure Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global positive airway pressure devices market report based on product, application, end use, and region:

  • Product Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
  • CPAP
  • APAP
  • BiPAP
  • Application Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
  • Obstructive Sleep Apnea
  • Respiratory Failures
  • COPD
  • End Use Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
  • Home Care Settings
  • Hospitals & Clinics
  • Others (Long-Term Care Facilities, etc.)
  • Regional Outlook (Volume, 000'Units; Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Positive Airway Pressure Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Obstructive Sleep Apnea (OSA)
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Supportive Initiatives by Government and Private Organizations for PAP Devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Product Recalls and Device Failures
      • 3.2.2.2. Patient discomfort and compliance issues
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Positive Airway Pressure Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Regulatory Overview
  • 3.5. Technology overview (current products vs. next-gen features)
  • 3.6. Major Deals & Strategic Alliances Analysis in the Positive Airway Pressure Devices
  • 3.7. COVID-19 Impact

Chapter 4. Positive Airway Pressure Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Positive Airway Pressure Devices Market: By Product, 2021 to 2033
    • 4.4.1. CPAP
      • 4.4.1.1. CPAP Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 4.4.2. APAP
      • 4.4.2.1. APAP Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 4.4.3. BiPAP
      • 4.4.3.1. BiPAP Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units

Chapter 5. Positive Airway Pressure Devices Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Positive Airway Pressure Devices Market: By Application, 2021 to 2033
    • 5.4.1. Obstructive Sleep Apnea
      • 5.4.1.1. Obstructive Sleep Apnea Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 5.4.2. Respiratory Failures
      • 5.4.2.1. Respiratory Failures Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 5.4.3. COPD
      • 5.4.3.1. COPD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units

Chapter 6. Positive Airway Pressure Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Positive Airway Pressure Devices Market: By End Use, 2021 to 2033
    • 6.4.1. Hospitals and Clinics
      • 6.4.1.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 6.4.2. Home Care Settings
      • 6.4.2.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units
    • 6.4.3. Others (Long-Term Care Facilities, etc.)
      • 6.4.3.1. Others (Long-Term Care Facilities, etc.) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million) (000') Units

Chapter 7. Positive Airway Pressure Devices Market: Regional Estimates & Trend Analysis by Region, Product, Application, End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Reimbursement Scenario
      • 7.3.1.4. Competitive scenario
      • 7.3.1.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Reimbursement Scenario
      • 7.3.2.4. Competitive scenario
      • 7.3.2.5. Canada market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Reimbursement Scenario
      • 7.3.3.4. Competitive scenario
      • 7.3.3.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Reimbursement Scenario
      • 7.4.1.4. Competitive scenario
      • 7.4.1.5. UK market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Reimbursement Scenario
      • 7.4.2.4. Competitive scenario
      • 7.4.2.5. Germany market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Reimbursement Scenario
      • 7.4.3.4. Competitive scenario
      • 7.4.3.5. France market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Reimbursement Scenario
      • 7.4.4.4. Competitive scenario
      • 7.4.4.5. Italy market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Reimbursement Scenario
      • 7.4.5.4. Competitive scenario
      • 7.4.5.5. Spain market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.6. Denmark
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Reimbursement Scenario
      • 7.4.6.4. Competitive scenario
      • 7.4.6.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Reimbursement Scenario
      • 7.4.7.4. Competitive scenario
      • 7.4.7.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework
      • 7.4.8.3. Reimbursement Scenario
      • 7.4.8.4. Competitive scenario
      • 7.4.8.5. Norway market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Reimbursement Scenario
      • 7.5.1.4. Competitive scenario
      • 7.5.1.5. Japan market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Reimbursement Scenario
      • 7.5.2.4. Competitive scenario
      • 7.5.2.5. China market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Reimbursement Scenario
      • 7.5.3.4. Competitive scenario
      • 7.5.3.5. India market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.5.4. South Korea
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Reimbursement Scenario
      • 7.5.4.4. Competitive scenario
      • 7.5.4.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.5.5. Thailand
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Reimbursement Scenario
      • 7.5.5.4. Competitive scenario
      • 7.5.5.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Reimbursement Scenario
      • 7.5.6.4. Competitive scenario
      • 7.5.6.5. Australia market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Reimbursement Scenario
      • 7.6.1.4. Competitive scenario
      • 7.6.1.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Reimbursement Scenario
      • 7.6.2.4. Competitive scenario
      • 7.6.2.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Reimbursement Scenario
      • 7.7.1.4. Competitive scenario
      • 7.7.1.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Reimbursement Scenario
      • 7.7.2.4. Competitive scenario
      • 7.7.2.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Reimbursement Scenario
      • 7.7.3.4. Competitive scenario
      • 7.7.3.5. UAE market estimates and forecasts 2021 to 2033 (USD Million) (000') Units
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Reimbursement Scenario
      • 7.7.4.4. Competitive scenario
      • 7.7.4.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million) (000') Units

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Market Share Analysis, CPAP Devices, 2024
  • 8.4. Company Market Share Analysis, APAP Devices, 2024
  • 8.5. Company Market Share Analysis, Bi-PAP Devices, 2024
  • 8.6. Company Categorization
  • 8.7. Company Profiles/Listing
    • 8.7.1. Koninklijke Philips N.V.
      • 8.7.1.1. Participant's Overview
      • 8.7.1.2. Financial Performance
      • 8.7.1.3. Product Benchmarking
      • 8.7.1.4. Strategy Mapping
    • 8.7.2. Fisher & Paykel Healthcare Limited
      • 8.7.2.1. Participant's Overview
      • 8.7.2.2. Financial Performance
      • 8.7.2.3. Product Benchmarking
      • 8.7.2.4. Strategy Mapping
    • 8.7.3. ResMed
      • 8.7.3.1. Participant's Overview
      • 8.7.3.2. Financial Performance
      • 8.7.3.3. Product Benchmarking
      • 8.7.3.4. Strategy Mapping
    • 8.7.4. Drive DeVilbiss Healthcare
      • 8.7.4.1. Participant's Overview
      • 8.7.4.2. Financial Performance
      • 8.7.4.3. Product Benchmarking
      • 8.7.4.4. Strategy Mapping
    • 8.7.5. React Health (3B Medical)
      • 8.7.5.1. Participant's Overview
      • 8.7.5.2. Financial Performance
      • 8.7.5.3. Product Benchmarking
      • 8.7.5.4. Strategy Mapping
    • 8.7.6. BMC Medical
      • 8.7.6.1. Participant's Overview
      • 8.7.6.2. Financial Performance
      • 8.7.6.3. Product Benchmarking
      • 8.7.6.4. Strategy Mapping
    • 8.7.7. Armstrong Medical Inc.
      • 8.7.7.1. Participant's Overview
      • 8.7.7.2. Financial Performance
      • 8.7.7.3. Product Benchmarking
      • 8.7.7.4. Strategy Mapping
    • 8.7.8. Wellell (Apex Medical)
      • 8.7.8.1. Participant's Overview
      • 8.7.8.2. Financial Performance
      • 8.7.8.3. Product Benchmarking
      • 8.7.8.4. Strategy Mapping
    • 8.7.9. Breas Medical
      • 8.7.9.1. Participant's Overview
      • 8.7.9.2. Financial Performance
      • 8.7.9.3. Product Benchmarking
      • 8.7.9.4. Strategy Mapping
    • 8.7.10. SEFAM
      • 8.7.10.1. Participant's Overview
      • 8.7.10.2. Financial Performance
      • 8.7.10.3. Product Benchmarking
      • 8.7.10.4. Strategy Mapping
    • 8.7.11. Trudell Medical (Vyaire)
      • 8.7.11.1. Participant's Overview
      • 8.7.11.2. Financial Performance
      • 8.7.11.3. Product Benchmarking
      • 8.7.11.4. Strategy Mapping
    • 8.7.12. Lowenstein Medical UK Ltd
      • 8.7.12.1. Participant's Overview
      • 8.7.12.2. Financial Performance
      • 8.7.12.3. Product Benchmarking
      • 8.7.12.4. Strategy Mapping
    • 8.7.13. Transcend Inc. (Somnetics International, Inc.)
      • 8.7.13.1. Participant's Overview
      • 8.7.13.2. Financial Performance
      • 8.7.13.3. Product Benchmarking
      • 8.7.13.4. Strategy Mapping

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 4. North America positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 5. North America positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 6. U.S. positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 7. U.S. positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 8. U.S. positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 9. Canada positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 10. Canada positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 11. Canada positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 12. Mexico positive airway pressure devices market estimates and forecasts, by product, 2021-2033 (USD Million) (000' Units)
  • Table 13. Mexico positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 14. Mexico positive airway pressure devices market estimates and forecasts by end use, 2021-2033 (USD Million) (000' Units)
  • Table 15. Europe positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 16. Europe positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 17. Europe positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 18. UK positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 19. UK positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 20. UK positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 21. Germany positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 22. Germany positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 23. Germany positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 24. France positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 25. France positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 26. France positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 27. Italy positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 28. Italy positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 29. Italy positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 30. Spain positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 31. Spain positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 32. Spain positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 33. Sweden positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 34. Sweden positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 35. Sweden positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 36. Denmark positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 37. Denmark positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 38. Denmark positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 39. Norway positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 40. Norway positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 41. Norway positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 42. Asia Pacific positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 43. Asia Pacific positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 44. Asia Pacific positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 45. Japan positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 46. Japan positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 47. Japan positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 48. China positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 49. China positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 50. China positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 51. India positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 52. India positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 53. India positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 54. Australia positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 55. Australia positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 56. Australia positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 57. South Korea positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 58. South Korea positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 59. Thailand positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 60. Thailand positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 61. Thailand positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 62. Latin America positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 63. Latin America positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 64. Latin America positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 65. Brazil positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 66. Brazil positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 67. Brazil positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 68. Argentina positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 69. Argentina positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 70. Argentina positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 71. MEA positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 72. MEA positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 73. MEA positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 74. South Africa positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 75. South Africa positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 76. South Africa positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 77. Saudi Arabia positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 78. Saudi Arabia positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 79. Saudi Arabia positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)
  • Table 80. UAE positive airway pressure devices market estimates and forecasts, by product, 2021 - 2033 (USD Million) (000' Units)
  • Table 81. UAE positive airway pressure devices market estimates and forecasts, by application, 2021 - 2033 (USD Million) (000' Units)
  • Table 82. UAE positive airway pressure devices market estimates and forecasts by end use, 2021 - 2033 (USD Million) (000' Units)

List of Figures

  • Fig. 1 Positive Airway Pressure Devices Market Segmentation
  • Fig. 2 Information Procurement
  • Fig. 3 Data Analysis Models
  • Fig. 4 Market Formulation and Validation
  • Fig. 5 Data Validating & Publishing
  • Fig. 6 Market Snapshot
  • Fig. 7 Segment Snapshot (1/2)
  • Fig. 8 Segment Snapshot (2/2)
  • Fig. 9 Competitive Landscape Snapshot
  • Fig. 10 Positive Airway Pressure Devices- Market Size and Growth Prospects (USD Million)
  • Fig. 11 Positive Airway Pressure Devices Market: Industry Value Chain Analysis
  • Fig. 12 Positive Airway Pressure Devices Market: Market Dynamics
  • Fig. 13 Positive Airway Pressure Devices Market: PORTER's Analysis
  • Fig. 14 Positive Airway Pressure Devices Market: PESTEL Analysis
  • Fig. 15 Positive Airway Pressure Devices Market Share by Product 2024 & 2033 (USD Million) (000' Units)
  • Fig. 16 Positive Airway Pressure Devices Market, by Product: Market Share, 2024 & 2033
  • Fig. 17 Smart Inhalers and Nebulizers Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 18 CPAP Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 19 APAP Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 20 BiPAP Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 21 Positive Airway Pressure Devices Market, by Application: Key Takeaways
  • Fig. 22 Positive Airway Pressure Devices Market, by Application: Market Share, 2024 & 2033
  • Fig. 23 Obstructive Sleep Apnea Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 24 Respiratory Failures Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 25 COPD Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 26 Positive Airway Pressure Devices Market, by End Use: Key Takeaways
  • Fig. 27 Positive Airway Pressure Devices Market, by End Use: Market Share, 2024 & 2033
  • Fig. 28 Hospitals and Clinics Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 29 Home Care Settings Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 30 Others (Long-Term Care Facilities, etc.) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million, 000' Units)
  • Fig. 31 Positive Airway Pressure Devices Market Revenue, by Region, 2024 & 2033 (USD Million) (000' Units)
  • Fig. 32 Regional Marketplace: Key Takeaways
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 North America Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 35 U.S. Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 36 Canada Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 37 Mexico Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 38 Europe Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 39 UK Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033) (USD Million) (000' Units)
  • Fig. 40 Germany Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 41 France Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 42 Italy Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 43 Spain Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 44 Sweden Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 45 Denmark Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 46 Norway Positive Airway Pressure Devices Market Estimates and Forecasts, (2021 - 2033) (USD Million) (000' Units)
  • Fig. 47 Asia Pacific Positive Airway Pressure Devices Market Estimates and Forecast, 2021 - 2030 (USD Million) (000' Units)
  • Fig. 48 Japan Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 49 China Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 50 India Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 51 Australia Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 52 Thailand Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 53 Latin America Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 54 Brazil Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 55 Argentina Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million) (000' Units)
  • Fig. 56 MEA Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2030 (USD Million) (000' Units)
  • Fig. 57 Saudi Arabia Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2030 (USD Million) (000' Units)
  • Fig. 58 UAE Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2030 (USD Million) (000' Units)
  • Fig. 59 South Africa Positive Airway Pressure Devices Market Estimates and Forecasts, 2021 - 2030 (USD Million) (000' Units)
  • Fig. 60 Key Company Categorization
  • Fig. 61 Company Market Positioning
  • Fig. 62 Key Company Market Share Analysis, 2024
  • Fig. 63 Strategic Framework